Jennison Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,570
Closed -$587K 581
2025
Q3
$587K Sell
19,570
-12,191
-38% -$344K ﹤0.01% 522
2025
Q2
$909K Buy
+31,761
New +$945K ﹤0.01% 494
2024
Q3
Sell
-54,488
Closed -$1.31M 560
2024
Q2
$1.31M Buy
54,488
+9,117
+20% +$224K ﹤0.01% 466
2024
Q1
$1.23M Buy
45,371
+9,036
+25% +$257K ﹤0.01% 482
2023
Q4
$1.01M Buy
36,335
+9,106
+33% +$237K ﹤0.01% 489
2023
Q3
$763K Buy
+27,229
New +$798K ﹤0.01% 493
2022
Q3
Sell
-31,490
Closed -$938K 602
2022
Q2
$938K Sell
31,490
-1,730
-5% -$49.7K ﹤0.01% 527
2022
Q1
$874K Buy
+33,220
New +$823K ﹤0.01% 574
2017
Q4
Sell
-401,068
Closed -$20.4M 650
2017
Q3
$20.4M Sell
401,068
-2,099
-0.5% -$112K 0.02% 402
2017
Q2
$23.4M Sell
403,167
-8,807
-2% -$512K 0.02% 383
2017
Q1
$24.1M Buy
+411,974
New +$23.4M 0.03% 402

Other funds holding ALKS

Jennison Associates's ALKS Position: Q4 2025 in Review

Jennison Associates sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 19,570 shares — an estimated $587K sold.

Jennison Associates first reported a position in ALKS in Q1 2017 and held it in 11 quarters. The position peaked at $24.1M in Q1 2017. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

  • Jennison Associates reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
  • Jennison Associates sold 19,570 Alkermes shares in Q4 2025, an estimated $587K.
  • Jennison Associates first reported a position in Alkermes in Q1 2017 and held it in 11 quarters.
  • Jennison Associates's Alkermes position peaked at $24.1M in Q1 2017.
  • 366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.